Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump's ...

Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump's ...

The visit also served as an opportunity to explore how UNAIDS can support South Africa’s G20 Presidency and the country’s ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

More than half a million people previously diagnosed with HIV have started on HIV treatment since the end of February, the health minister says. But can a big jump in 10 weeks really be? We look at ...

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV vaccine in Africa, where the burden of the virus is still being keenly felt.